Delivery Order SPE2DB22D3016-SPE2DB24FBDA2

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $13,252.92 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract provides for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,284.74 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,977.15 delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) and has a completion date of April 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,717.80 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves...
This federal contract award, valued at $26,875.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens and has a completion date of June 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $8,985.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $7,691.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of October 24, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award, valued at $12,077.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication, with a performance period through April 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.08 Firm Fixed Price Delivery Order covers the supply of Ozempic 0.25-0.5 mg/dose pens, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.88 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBDA2
    Delivery Order

This federal contract award, valued at $2,087.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to support military healthcare programs. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, potentially worth up to $999,999,999 through December 2025, for a comprehensive range of medical commodities. The contract has no set-aside designation and is a firm-fixed-price delivery order with an ultimate completion date of August 6, 2024. As a leading pharmaceutical supplier to the federal government, Amerisourcebergen leverages its extensive distribution network to provide essential medications and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/4/24, 10:29 AM